Documentos de Académico
Documentos de Profesional
Documentos de Cultura
November 2015
Metabolic Syndrome Risk Factors and their triggering mechanisms and
complications. (A literature review).
Alumno: Carlos Jimnez Beltrn
Universidad de Sonora
Campus Cajeme
Divisin de Ciencias de la Salud.
Licenciatura en Medicina.
Correo electrnico: carlosjb_448@hotmail.com
Abstract. Metabolic syndrome its a pathophysiologic entity of multifactorial cause that predisposes the
person to developing chronic degenerative diseases, mostly cardiovascular type; where currently causal
mechanism it is a largely unknown. The parameters that define and aid on the search of it prognosis are
numerous, but all of them, five manifestations have remained constant and were included as factors guide
in the IDF definition for metabolic syndrome: presence of central obesity (based on the waist
circumference), high serum levels for triglycerides, LDL cholesterol, elevated blood pressure, and low
serum levels for HDL cholesterol. The insulin resistance and central obesity represents the most
characteristic conditions and they accuse of being the events that trigger the appearance of other factors
and consequently complications on the health status of the person. The mechanism that develop this
disorder are multiple and still being discovered. There agents, both exogenous such endogenous, that can
trigger this poor health status; but exists natural systems of the body which they are designed to fight the
said agents and promotes a stable physiological state. Complications are varied, mainly focused on
vascular injury and cell signaling, that condition to multiple pathologies such a CVD, DMT2, dyslipidemia,
liver or kidney failure, hypertension, cutaneous manifestations, erectile dysfunction, etc.
Introduccin
Federation)1
se
(Internacional
Diabetes
abdominal,
hipertensin.
colesterol
alto
metablicos.
El sndrome metablico
Antecedentes histricos
para
de
las
riesgo
sndrome
siglo
investigaciones
del
XX
SM.
el
El
dedicadas
termino
SM
recibi
mltiples
triglicridos,
lipoprotena
diagnostico
encuentran
plurimetablico
1996) y ms. 2
del
alta
probable
de
sndrome
Obesidad e Insulino-Resistencia.
Relacin y Fisiopatogenia
Tratamiento de la Hipercolesterolemia en
Colesterol de Alta
Densidad (HDL-c)
Presin Arterial
Alta (Hipertensin)
Glucosa srica
en ayuno
sustancias
angiotensingeno,
despus
en
es
almacenada
primero
pro-inflamatorias,
CETP
(Protena
central;
acciones
La
grasa
visceral
presenta
se
ciertas
inflamacin
anteriormente
citados
La produccin de EROs
Disfuncin
mitocondrial:
Estudios
neurodegenerativas
como
de
mutacin
de
los
genes
fisiopatolgicos
por
los
cuales
los
antes
cuadro 2. 7
mencionadas
para
xenobioticos,
un
importante
sistema
2.
3.
4.
5.
6.
7.
notablemente
los
niveles
de
de
las
cardiovasculares.
enfermedades
La
inactividad
crnicas
fsica
general, lo
La
uno.
glucotoxicidad
lipotoxicidad
subsecuentes
incluyen
cardiovasculares,
al
estado
enfermedades
microvasculares
Dislipidemia
cual
elevacin
vez
VLDL
funcin
diabetes,
estimula
la
produccin
de
incrementa
de
la
produccin
catecolaminas
endotelial.
El
incrementa
del
(sobretodo
glucagn,
la
que
actividad
Acantosis nigricans
Hipertensin
semejante
una
mancha
de
mugre,
aparicin de ella. 7
Disfuncin erctil
en
recibi
mltiples
se
metablico
escasa
produccin
de
las variables ms
frecuentemente
ambientales
continua
podran
que
alterar
de
forma
el
estado
Conclusin
factores
para
de
que
riesgo
el
complicaciones
que
paciente
de
componen
no
esta
la
desarrolle
alteracin
de
desarrollar
enfermedad
Referencias
1. S/A. The IDF consensus worldwide definition
of the metabolic sndrome. Federacin
Internacional de la Diabetes (IDF). 2006
Recuperado
de:
http://www.idf.org/webdata/docs/MetS_def
_update2006.pdf
2. Cordoba-Pluma VH, Castro-Martinez G,
Rubio-Guerra A, Hegewisch ME. Breve crnica
de la definicin del sndrome metablico.
Med Int Mx 2014;30:312-328.
3. Stolar M. Metabolic syndrome: Controversial
but useful. Cleveland Clinic Journal of
Medicine 2007, 74:3 199-208. Recuperado
de:
http://www.ccjm.org/viewpdf.html?file=fileadmin/content_pdf/ccjm/c
ontent_74_199 22/Nov/15
4. Brodman DJ, Girod JP. The metabolic
syndrome: A tug-of-war with no winner.
Cleveland Clinic Journal of Medicine 2002,
69:12
990-994.
Recuperado
de:
http://www.ccjm.org/viewpdf.html?file=fileadmin/content_pdf/ccjm/c
ontent_69_990 22/Nov/15
5. Lam DW, LeRoith D. Metabolic Syndrome.
Source Endotext [Internet]. South Dartmouth
(MA): MDText.com, Inc.; 2000-2015 May 19
(Last
Update).
Recuperado
de:
http://www.ncbi.nlm.nih.gov/books/NBK278
936/ 22/Nov/15
6. Corona JC, Duchen MR S et al. PPAR and PGC1 as Therapeutic Targets in Parkinsons.
Neurochem Res, 2015 40:308316
7. Zhou SS, et al. Skin function: a factor antimetabolic
syndrome.
Diabetology
&
Metabolic Syndrome 2012, 4:15
8. Shuval K, et al. Standing, Obesity, and
Metabolic Syndrome: Findings From the
Cooper Center Longitudinal Study. Mayo Clin
Proc. 2015;90(11):1524-1532